论文部分内容阅读
目的探讨血液滤过联合血液灌流治疗急性重症胰腺炎患者的临床效果。方法选取2013年8月至2015年1月鞍山市双山医院收治的23例急性重症胰腺炎患者作为研究对象,所有患者均给予血液滤过联合血液灌流进行治疗,观察并记录患者的临床疗效及治疗前后的体温、心率、平均动脉压、中心静脉压。结果 23例患者经治疗后总有效率为95.7%(22/23);治疗后,患者的体温、心率、平均动脉压、中心静脉压均明显低于治疗前,差异均有统计学意义(均P<0.05)。结论血液滤过联合血液灌流治疗急性重症胰腺炎患者临床效果明显,可提高患者的生命质量,减轻腹痛、腹胀,使其早日恢复。
Objective To investigate the clinical effect of hemofiltration and hemoperfusion on acute severe pancreatitis. Methods Twenty-three patients with acute severe pancreatitis treated at Anshan Shuangshan Hospital from August 2013 to January 2015 were enrolled in this study. All patients were treated with hemofiltration combined with hemoperfusion to observe and record the clinical efficacy and Body temperature before and after treatment, heart rate, mean arterial pressure, central venous pressure. Results The total effective rate of the 23 patients after treatment was 95.7% (22/23). After treatment, the patients’ body temperature, heart rate, mean arterial pressure and central venous pressure were significantly lower than those before treatment, both of which were statistically significant P <0.05). Conclusion Hemofiltration combined with hemoperfusion treatment of acute severe acute pancreatitis patients with significant clinical effects, can improve the quality of life of patients, reduce abdominal pain, abdominal distension, to make an early recovery.